Collectively, hepatic macrophages (BM-MΦ, BM-KCs, KCs) augment metabolic disease during NASH; hepatic steatosis, insulin resistance, and oral glucose tolerance improve in mice with fibrotic NASH following depletion of hepatic macrophages (64, 74–76). This evidence concerns the gene TBCE and fatty liver disease.